Souvenaid® liquid has been shown to be safe and well tolerated when used alone or alongside common Alzheimer’s disease medication^1-4 in various studies and is not expected to result in unwanted side effects. Souvenaid® is backed by 20 years of evidence-based research, supported by an ongoing research program.^1-4

Souvenaid®'s proven safety and tolerability for most patients makes it suitable for various dietary needs:

• Souvenaid® is classified as a low-GI product.
• Souvenaid® liquid is free from gluten-containing ingredients (<20mg/kg).
• Souvenaid® contains ingredients obtained from milk, fish oil and soy, and therefore is not suitable for people who have allergies to these foods.
• Souvenaid® liquid is low lactose (<300mg/kg).
• Souvenaid® is not suitable for people with galactosaemia.
• Souvenaid® is not suitable as a sole source of nutrition and should be used in addition to normal dietary intake.

People with diabetes can also use Souvenaid®, however it does contain carbohydrates. If you have diabetes, as with other foods containing carbohydrates, it's advised you monitor your blood glucose levels when using Souvenaid®, with the help of your medical team.

Souvenaid® liquid has been shown to be safe and well tolerated when used alone or alongside common Alzheimer’s disease medications^1-3,6-8. However, you should always consult your healthcare professional before beginning to use Souvenaid®, or when commencing a new medication alongside Souvenaid®.

Although unwanted symptoms are not expected when using Souvenaid®, speak to your doctor or healthcare professional if you’re concerned about any side effects.

Alzheimer’s disease affects up to 1 in 10 Australians over the age of 65,⁷ making it the most common form of dementia in Australia.⁸ The progressive brain degeneration which occurs with Alzheimer’s disease affects memory, thinking skills, emotions, behaviour and mood. As a result, your ability to carry out daily activities becomes impaired over time.⁸ There is currently no cure and treatment options are limited, especially for patients in the early stages of Alzheimer’s disease,⁹ meaning nutritional and lifestyle modifications are currently one of the recommended ways to help manage the condition and its associated symptoms.

Souvenaid® is a medical nutrition drink that has been formulated to nutritionally support memory function in  early Alzheimer’s disease including mild cognitive impairment (MCI).

Research has shown that people with Alzheimer’s disease including MCI often have low levels of some key nutrients including vitamins A, C, E, folate, choline, vitamin B12 and Omega-3.^10,11 The brain needs key nutrients in the right combination and at the right level to support the formation of new brain connections, known as synapses.  Souvenaid® has been specially formulated to provide these essential nutrients at levels otherwise difficult to achieve through normal diet alone, to nutritionally support the growth of these connections within the brain, known as synapses⁹.

Souvenaid® is backed by 20 years of evidence-based research, supported by an ongoing research program.

Listen to Bill’s inspiring, personal story of how he manages his diagnosis with lifestyle changes including Souvenaid®.

*Incentive was provided for this testimonial.

Check out more positive testimonials from Souvenaid users here.

For more information about Souvenaid®, check out the following resources:

Souvenaid® is a Food for Special Medical Purpose for the dietary management of early Alzheimer’s disease. Must be used under medical supervision. Souvenaid® does not cure or alleviate Alzheimer’s disease.

Nothing in this article is to be substituted for medical advice, always consult your medical professional for any health concerns.

^Based on a study published in 2021. Individual results may vary. This product does not cure or alleviate Alzheimer’s disease.